Narrow your search

Library

KU Leuven (12)

ULB (11)

ULiège (11)

Odisee (10)

Thomas More Kempen (10)

Thomas More Mechelen (10)

UCLL (10)

VIVES (10)

LUCA School of Arts (6)

VDIC (6)

More...

Resource type

book (15)


Language

English (12)

French (3)


Year
From To Submit

2015 (1)

2014 (1)

2013 (1)

2012 (3)

2010 (3)

More...
Listing 11 - 15 of 15 << page
of 2
>>
Sort by
Angiogenesis Protocols
Author:
ISBN: 0896036987 9786610821082 1280821086 1592591434 9780896036987 Year: 2001 Volume: 46 Publisher: Totowa, NJ : Humana Press : Imprint: Humana,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Although angiogenesis-the formation of new blood vessels from pre-existing ones-has emerged as an exciting new target for the treatment of many varied disorders, fundamental aspects of this important biological process remain poorly understood. To address the needs of those working in such a dramatically advancing area, Cliff Murray and a panel of experienced investigators have brought together in Angiogenesis Protocols a comprehensive collection of key techniques for assessing the formation of new blood vessels in both whole tissues and cell culture. These readily reproducible methods range from low-cost in vitro assays to cutting-edge in vivo models, such as the dorsal window chamber, which demands high levels of surgical skill as well as relatively expensive, custom-made equipment. The authors have also included details of the associated techniques for the isolation, identification, and culture of microvessel endothelial cells from human adipose tissues and for the transfection and transduction of primary human endothelial cells. Timely and highly practical, Angiogenesis Protocols is a gold-standard resource for today's angiogenesis investigator, providing easy access to a wide variety of proven assays suitable for laboratories with greatly differing technical expertise, materials, and financial resources.


Book
The Tumor Microenvironment
Author:
ISBN: 1441966145 9786612983009 1441966153 1282983008 Year: 2010 Publisher: New York, NY : Springer New York : Imprint: Humana,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The field of cancer biology and developmental therapeutics is continually evolving as new methodologies are developed and new targets are discovered. Although multiple therapeutics directly target the malignant cells these drugs rarely prevent recurrence of disease or the progression of metastasis. The complex biology of tumors presents challenges in designing treatments that will eliminate the malignant cells as well as the supporting network of vasculature and stroma that allows for the comparison of tumors to developing organs in embryos. In addition to blood vessels and malignant cells, tumors consist of fibroblasts, immune and inflammatory cells, and a myriad of proteins that comprise the extracellular matrix. Effective eradication of malignant disease requires therapeutic strategies that factor in targeting the tumor microenvironment. In the past decade, a new class of anticancer drugs has emerged that interferes with tumor angiogenesis; however the clinical benefit from treatment with the first generation antiangiogenic agents added to the standard of care is often modest. Thus, there remains a critical need to understand the tumor microenvironment and to develop anti-cancer therapies that address this aspect of malignant disease. The first edition of The Tumor Microenvironment is intended to give a current perspective on the role of the tumor microenvironment in malignant progression and detail strategies for novel therapies directed towards the cellular matrix. This book explores the many biological and physiological aspects of the tumor as a tissue and includes chapters on the variety of cells that influence tumor growth and spread as well as the cell-associated and soluble proteins that can promote invasion and metastasis. Several chapters describe endothelial cells and pericytes that form tumor vasculature. Insights into the role of progenitor and stem cells are included. The contribution of the supporting stroma is addressed in addition to cell-cell signaling and cell-matrix interactions. Additional chapters describe the influence of infiltrating cells of the immune system on tumor growth. The Tumor Microenvironment is the definitive text detailing cutting edge research by experts in the field and will be a valued resource in the study of this important area of cancer biology for many years to come.

Keywords

Cancer cells -- Regulation. --- Cancer cells. --- Cancer invasiveness. --- Carcinogenesis. --- Tumors -- Metabolism. --- Carcinogenesis --- Tumors --- Cancer cells --- Chemistry, Pharmaceutical --- Angiogenesis Modulating Agents --- Cell Physiological Phenomena --- Medicine --- Diseases --- Growth Inhibitors --- Antineoplastic Agents --- Stem Cells --- Investigative Techniques --- Pharmacology --- Therapeutic Uses --- Growth Substances --- Phenomena and Processes --- Chemistry --- Cells --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Health Occupations --- Neoplasms --- Angiogenesis Inhibitors --- Tumor Microenvironment --- Drug Discovery --- Pathology --- Neoplastic Stem Cells --- Biological Science Disciplines --- Anatomy --- Physiological Effects of Drugs --- Natural Science Disciplines --- Disciplines and Occupations --- Pharmacologic Actions --- Chemical Actions and Uses --- Chemicals and Drugs --- Health & Biological Sciences --- Oncology --- Metabolism --- Growth --- Physiology, Pathological --- Tumors. --- Tumours --- Medicine. --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemicals --- Chemotherapy --- Drugs --- Pharmacy --- Cancer research --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Physicians --- Physiological effect --- Pathology, Cellular --- Cysts (Pathology) --- Oncology. --- Toxicology. --- Poisoning --- Poisons --- Toxicology


Book
History of Research on Tumor Angiogenesis
Author:
ISBN: 1402095597 9048181569 9786611954796 1281954799 1402095635 Year: 2009 Publisher: Dordrecht : Springer Netherlands : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

In 1971, J. Folkman published in the "New England Journal of Medicine" a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept that tumors probably secrete diffusible molecules that could stimulate the growth of new blood vessels toward the tumor and that the resulting tumor neovascularization could conceivably be prevented or interrupted by angiogenesis inhibitors. Solid and haematological tumors consist of an avascular and a subsequent vascular phase. Assuming that this depends on the release of angiogenic factors, acquisition of angiogenic capability can be seen as an expression of progression from neoplastic transformation to tumor growth and metastasis. Beginning in the 1980's, the biopharmaceutical industry began exploiting the field of antiangiogenesis for creating new therapeutic compounds for modulating new blood vessels in tumor growth. In 2004, Avastin (Bevacizumab), a humanized anti-VEGF monoclonal antibody, was the first angiogenesis inhibitor approved by the Food and Drug Administration for the treatment of colorectal cancer. At present, it has been estimated that over 20,000 cancer patients worldwide have received experimental form of antiangiogenic therapy. This book offers a historical account of the relevant literature. It also emphasizes the crucial and paradigmatic role of angiogenesis as a biological process and the significance of antiangiogenic approach for the treatment of tumors.

Keywords

Neovascularization inhibitors. --- Neovascularization. --- Tumors -- Blood-vessels -- Growth. --- Tumors. --- Tumors --- Neovascularization --- Neovascularization inhibitors --- Cardiovascular Physiological Processes --- Growth Inhibitors --- Metaplasia --- Metabolic Phenomena --- Antineoplastic Agents --- Growth Substances --- Diseases --- Science --- Physiological Effects of Drugs --- Pathologic Processes --- Therapeutic Uses --- Natural Science Disciplines --- Cardiovascular Physiological Phenomena --- Phenomena and Processes --- Pharmacologic Actions --- Circulatory and Respiratory Physiological Phenomena --- Disciplines and Occupations --- Pathological Conditions, Signs and Symptoms --- Chemical Actions and Uses --- Chemicals and Drugs --- Neoplasms --- Angiogenesis Inhibitors --- Angiogenesis Modulating Agents --- Neovascularization, Physiologic --- Neovascularization, Pathologic --- Research --- Metabolism --- Medicine --- Health & Biological Sciences --- Oncology --- Blood-vessels --- Growth --- Blood-vessels. --- Treatment. --- Cancer --- Tumours --- Medicine. --- History. --- Cancer research. --- Oncology. --- Pathology. --- Cell biology. --- Biomedicine. --- Cancer Research. --- History of Science. --- Cell Biology. --- Pathology --- Cysts (Pathology) --- Oncology  . --- Cytology. --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Annals --- Auxiliary sciences of history --- Cancer research

Tumor Angiogenesis : Basic Mechanisms and Cancer Therapy
Authors: ---
ISBN: 9783540331766 354033176X 9786611139964 1281139963 3540331778 Year: 2008 Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Preface Tumor development and progression occur as a result of cumulative acquisition of genetic alterations affecting oncogenes and tumor suppressor genes. As a consequence of these alterations the arising tumor gains some fatal properties such as increased cell proliferation and decreased apoptosis, resulting in a net accumulation of tra- formed cells. Once a critical volume is achieved, lack of oxygen and nutrients limits further growth. To overcome this obstacle, the tumor cells initiate a program focused on the formation of new blood vessels within the host tissue. This process is termed tumor angiogenesis and contributes to the progression of most solid tumors and the formation of metastases. Since its discovery more than 30 years ago by Dr. Judah Folkman, tumor angiog- esis has been proposed as an ideal target for novel tumor therapies. Today the first anti-angiogenic compounds are available for the treatment of patients but their s- cess in the clinic is rather limited when given as monotherapies. This is in contrast to many preclinical results which revealed a much higher efficacy of these therapeutics in appropriate animal models. The reasons for this discrepancy are manifold, one being the existence of more than one angiogenic signaling system capable of driving tumor angiogenesis. Therefore it is no surprise that the inhibition of just one system is not sufficient to block the formation of new blood vessels in patients.

Keywords

Neoplasms --- Angiogenesis Inhibitors --- Neovascularization, Pathologic --- Neovascularization inhibitors --- Tumors --- Neovascularization --- Néovascularisation --- Tumeurs --- drug therapy. --- therapeutic use. --- blood supply. --- Blood-vessels --- Inhibiteurs --- Vaisseaux sanguins --- Cancer -- Treatment. --- Tumors -- Blood-vessels. --- Tumors. --- Angiogenesis Modulating Agents --- Antineoplastic Agents --- Growth Inhibitors --- Diseases --- Metaplasia --- Growth Substances --- Pathologic Processes --- Therapeutic Uses --- Pathological Conditions, Signs and Symptoms --- Physiological Effects of Drugs --- Pharmacologic Actions --- Chemical Actions and Uses --- Chemicals and Drugs --- Oncology --- Medicine --- Health & Biological Sciences --- Antineoplastic agents. --- Neovascularization inhibitors. --- Neovascularization. --- Blood-vessels. --- Néovascularisation --- EPUB-LIV-FT LIVMEDEC LIVSANTE SPRINGER-B --- Angiogenesis --- Cancer --- Angiogenesis inhibitors --- Tumor angiogenesis inhibitors --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Medicine. --- Cancer research. --- Molecular biology. --- Pharmacology. --- Oncology. --- Medicine & Public Health. --- Cancer Research. --- Molecular Medicine. --- Pharmacology/Toxicology. --- Antineoplastic agents --- Drugs --- Chemotherapy --- Growth --- Oncology  . --- Toxicology. --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Toxicology --- Health Workforce --- Drug effects --- Medical pharmacology --- Pharmacy --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Cancer research --- Physiological effect


Book
Biochemical Basis and Therapeutic Implications of Angiogenesis
Authors: ---
ISBN: 1489991670 1461458560 1461458579 Year: 2013 Publisher: New York, NY : Springer New York : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Angiogenesis plays a key role in human physiology and pathophysiology. While necessary for tissue growth and development, uncontrolled angiogenesis plays a role in the progression of certain tumors as well as atherosclerosis. Lack of angiogenesis may be the basis of myocardial ischemia and stroke. Knowledge on the mechanisms of angiogenesis is growing very rapidly, and may lead to important drugs for therapy of a variety of clinical disorders. Experts from around the world have contributed a vast array of data on different aspects of angiogenesis in this volume edited by Professors Mehta and Dhalla. This information will be of immense help to basic scientists, clinicians and those involved in drug development.

Keywords

Angiogenesis inducing agents. --- Neovascularization -- Therapeutic use. --- Neovascularization, Pathologic. --- Neovascularization. --- Neovascularization --- Metaplasia --- Biological Science Disciplines --- Cardiovascular Physiological Processes --- Growth Substances --- Natural Science Disciplines --- Pathologic Processes --- Cardiovascular Physiological Phenomena --- Physiological Effects of Drugs --- Disciplines and Occupations --- Circulatory and Respiratory Physiological Phenomena --- Pharmacologic Actions --- Pathological Conditions, Signs and Symptoms --- Phenomena and Processes --- Chemical Actions and Uses --- Diseases --- Chemicals and Drugs --- Neovascularization, Pathologic --- Physiology --- Angiogenesis Modulating Agents --- Neovascularization, Physiologic --- Human Anatomy & Physiology --- Health & Biological Sciences --- Anatomy --- Therapeutic use --- Blood-vessels. --- Cardiovascular system. --- Circulatory system --- Vascular system --- Angiology --- Vasculature --- Medicine. --- Cancer research. --- Human physiology. --- Molecular biology. --- Cardiology. --- Proteins. --- Stem cells. --- Biomedicine. --- Human Physiology. --- Cancer Research. --- Receptors. --- Molecular Medicine. --- Stem Cells. --- Blood --- Cardiovascular system --- Circulation --- Oncology. --- Cell receptors. --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Cells --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Cell membrane receptors --- Cell surface receptors --- Receptors, Cell --- Binding sites (Biochemistry) --- Cell membranes --- Proteins --- Tumors --- Heart --- Internal medicine --- Human body --- Health Workforce --- Proteins . --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Proteids --- Polypeptides --- Proteomics --- Cancer research --- Cancer. --- Medicine --- Biology --- Cancer Biology. --- Biomedical Research. --- Stem Cell Biology. --- Research. --- Biological research --- Biomedical research --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors

Listing 11 - 15 of 15 << page
of 2
>>
Sort by